Question

In: Statistics and Probability

A researcher is creating a new treatment protocol for Myelodysplastic Syndrome (MDS), a form of preleukemia....

A researcher is creating a new treatment protocol for Myelodysplastic Syndrome (MDS), a form of preleukemia. Following the old treatment protocol, 32% of patients with MDS will develop leukemia within 5 years of MDS diagnosis. He believes his new treatment protocol will lead to fewer MDS patients developing leukemia. He takes a random sample of 100 individuals on his new treatment protocol. Of these 100 individuals, 27 develop leukemia within 5 years of MDS diagnosis.

Create a 99.8% confidence interval for the true proportion of all MDS patients on this treatment who will develop leukemia within 5 years of MDS diagnosis.

What is the 99.8% confidence interval? What is the correct interpretation of the confidence interval? Are the assumptions met? Explain.

Conduct a hypothesis test at the 0.05 significance level to test this claim

What are the hypotheses? What is the significance level? What is the value of the test statistic? What is the p-value?

What is the correct decision? A. Reject the Null Hypothesis B. Fail to Reject the Null Hypothesis C. Accept the Null Hypothesis D. Accept the Alternative Hypothesis

What is the appropriate conclusion/interpretation? Are the assumptions met? Explain.

Solutions

Expert Solution

[Used R-Software]

Given is the problem of testing of proportion.

R-commands and outputs:

p0=0.32 # specified population proportion
n=100 # sample size
x=27   
phat=x/n # sample proportion
phat
[1] 0.27
qhat=1-phat
qhat
[1] 0.73

alpha=1-99.8/100 # 99.8% is confidence level
alpha
[1] 0.002

# 99.8% confidence interval

100(1-alpha)% confidence interval is given by:


z=qnorm(1-alpha/2) # Critical value
z
[1] 3.090232
phat-z*sqrt(phat*qhat/n) # Lower limit
[1] 0.1328062
phat+z*sqrt(phat*qhat/n) # Upper limit
[1] 0.4071938

# 99.8% confidence interval is [ 0.1328062, 0.4071938]

######
Condition for one-sample proportion Z-test:
n*p >=10 and n*(1-p) >= 10, where n is the sample size and p denotes proportion.
Yes, the conditions are met.

# Null hypothesis-H0: p=p0 Versus
# Alternative hypothesis-H1: p < p0 (claim)

Test statistic is given by:


z0=(phat-p0)/sqrt(p0*(1-p0)/n) # value of test statistic
z0
[1] -1.071866
pnorm(z0) # p-value
[1] 0.1418901
alpha=0.05 # Significance level
# Here, p-value is greater than alpha, we fail to Reject the null hypothesis H0.

# Correct decision: Fail to Reject the Null Hypothesis
# Conclusion: Result is not significant. There is no enough evidence to conclude that new treatment lead to fewer MDS protocol.



Related Solutions

Use the following information for questions 1-10: A researcher is creating a new treatment protocol for...
Use the following information for questions 1-10: A researcher is creating a new treatment protocol for Myelodysplastic Syndrome (MDS), a form of preleukemia. Following the old treatment protocol, 32% of patients with MDS will develop leukemia within 5 years of MDS diagnosis. He believes his new treatment protocol will lead to fewer MDS patients developing leukemia. He takes a random sample of 100 individuals on his new treatment protocol. Of these 100 individuals, 27 develop leukemia within 5 years of...
Use the following information for questions 27-30: A researcher is creating a new treatment protocol for...
Use the following information for questions 27-30: A researcher is creating a new treatment protocol for Myelodysplastic Syndrome (MDS), a form of preleukemia.  Following the old treatment protocol, 33% of patients with MDS will develop Leukemia within 5 years of MDS diagnosis.  He believes his new treatment protocol will lead to fewer MDS patients developing Leukemia.  He takes a random sample of 100 individuals on his new treatment protocol.  Of these 100 individuals, 27 develop Leukemia within 5 years of MDS diagnosis.  The researcher decides...
Use the following information for questions 27-30: A researcher is creating a new treatment protocol for...
Use the following information for questions 27-30: A researcher is creating a new treatment protocol for Myelodysplastic Syndrome (MDS), a form of preleukemia. Following the old treatment protocol, 33% of patients with MDS will develop Leukemia within 5 years of MDS diagnosis. He believes his new treatment protocol will lead to fewer MDS patients developing Leukemia. He takes a random sample of 100 individuals on his new treatment protocol. Of these 100 individuals, 27 develop Leukemia within 5 years of...
Suppose a researcher is interested in the effectiveness of a new respiratory treatment drug aimed at...
Suppose a researcher is interested in the effectiveness of a new respiratory treatment drug aimed at increasing forced vital capacity (FVC) among children with respiratory illnesses. In this study, each patient treated with the study drug is frequency paired with another patient on a number of characteristics treated with a placebo to insure independence among samples. Assume the following table represents the FVC for each participant and the paired control. Participant Treated with new drug FVC (%) Participant Treated with...
Question 31 Suppose a researcher is interested in a new treatment plan for increasing CD4 cell...
Question 31 Suppose a researcher is interested in a new treatment plan for increasing CD4 cell count in immune-compromised patients with HIV. In order to investigate the new drug, the researcher gathers a group of 48 individuals with a mean CD4 count of 317 cells/mm3 after treatment with a standard deviation of 24.6. Test the hypothesis that the mean CD4 count has increased above the goal of 275 cells/mm3. Write out your hypotheses and correctly interpret your pvalue. (Use an...
Dan has a rare form of lung cancer. A new medical treatment is found that would...
Dan has a rare form of lung cancer. A new medical treatment is found that would treat Dan's cancer, and although it would not cure it, research indicates that it would likely extend dan’s life by two years allowing him to have a quality of life similar to what it was before he had cancer. After two years, Dan is most likely to see a rapid decline in his health and die within a few months. The cost of this...
Studies have shown that the use of oxygen for the treatment of Acute Coronary Syndrome is...
Studies have shown that the use of oxygen for the treatment of Acute Coronary Syndrome is now detrimental to the myocardium and may worsen patient outcomes. Discuss the evidence that brought about changes to paramedic clinical practice.
A researcher interested in the treatment of depression developed an intensive treatment program designed to teach...
A researcher interested in the treatment of depression developed an intensive treatment program designed to teach people to think positively. The researcher began the study by recruiting 50 college students who received extremely low scores on a well-validated measure of self-esteem. Each of the 50 participants agreed to attend four 1-hour therapy sessions per week for two weeks (for a total of eight sessions). Thirty-seven of the 50 original participants remained in the study and completed all eight sessions. At...
What is the role of physical activity/exercise in prevention, treatment and management of Metabolic Syndrome? In...
What is the role of physical activity/exercise in prevention, treatment and management of Metabolic Syndrome? In answering the question describe the following. 1. Describe Metabolic Syndrome and the metabolic risk factors associated with it. 2. How is physical activity/exercise or lack of relate to Metabolic Syndrome 3. Discuss the multiple factors that increase the risk of Metabolic Syndrome
What is the alcohol flush reaction (or syndrome)? What are its causes and treatment? A lot...
What is the alcohol flush reaction (or syndrome)? What are its causes and treatment? A lot of interesting research been done on this reaction to study its analytical, biochemical, medical and demographical impacts.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT